.svg){kind=small}
Where to Buy
Quality Drugs is stocked at 77 licensed dispensaries across Oregon, with the deepest coverage in Portland, Bend, Eugene, Klamath Falls, and Medford. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Quality Drugs operated as a single-category brand in September 2026, with Edible at 100.0% of sales and a month-over-month change of 18.61% alongside a year-over-year increase of 95.88%. Average price fell 29.25% year over year to $5.11 while the brand’s 24-month sales grew 154.74%, indicating volume expansion offsetting price compression. The combination of a full Edible concentration and a rank of 7 in Oregon suggests depth rather than breadth: the pattern implies the brand is scaling within one lane instead of diversifying, using price to accelerate unit velocity.
The lift in September 2026 MoM sales of 18.61% concurrent with a 95.88% YoY gain and a 29.25% YoY price decline signals a strategy that prioritizes unit growth over margin per unit, which helps defend and potentially improve a rank of 7 in Oregon. With Edible at 100.0% share and a 154.74% two-year sales expansion, the implication is a positioning oriented toward value-driven, high-throughput SKUs; this setup favors maintaining shelf space and repeat velocity but concentrates risk in a single category where further share gains must come from continued unit capture rather than mix shifts.
Competitive Landscape
Quality Drugs is ranked #7 in OR Edible in September 2026, improving 5 positions from #12 year over year and climbing 3 spots from #10 in June 2026, reaching its peak rank of #7 in September 2026; meanwhile, Wyld held at #1 year over year with a 4.3% sales increase and Gron / Grön stayed at #2 despite a 5.0% sales decline, indicating that Quality Drugs’ upward rank mobility is happening while top incumbents are stable or contracting, implying the brand is gaining share against a largely static top tier.
Notable Products
Super Sour Apple Gummy (100mg) posted the sharpest shift in September 2026 with a +37.4% month-over-month rise and a rank of 4, outpacing Cosmic Pop Gummy (100mg) at +33.2% in the number 1 spot. With Lifted Lime Gummy (100mg) up +33.0% at rank 6 and THC/CBD 2:1 Radiant Raspberry Gummy (100mg THC, 50mg CBD) up +32.8% at rank 2, eight of the top ten are Edible SKUs, indicating concentrated momentum within one format. The CBD/CBN/THC 1:1:1 Berry Bonanza Gumdrops 10-Pack (100mg CBD, 100mg CBN, 100mg THC) grew +26.6% at rank 7 while the adjacent Cherry Bomb Remix variant gained +6.1% at rank 8, signaling that multi-cannabinoid offerings are scaling but with uneven velocity. This pattern implies Quality Drugs is consolidating around flavor-forward Edible leaders while nurturing multi-cannabinoid extensions as a secondary growth vector.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
